Pei-Yi Chu

Summary

Affiliation: Tri-Service General Hospital
Country: Taiwan

Publications

  1. ncbi request reprint Primary superficial basal cell carcinoma of the nipple
    Pei Yi Chu
    Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho Su Memorial Hospital, Shih Lin, Taipei, Taiwan
    Ann Saudi Med 27:296-7. 2007
  2. ncbi request reprint A retroperitoneal bronchogenic cyst successfully treated by laparoscopic surgery
    Pei Yi Chu
    Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho Su Memorial Hospital, Shih Lin, Taipei, Taiwan
    Ann Saudi Med 27:199-200. 2007
  3. pmc CIP2A is a target of bortezomib in human triple negative breast cancer cells
    Ling Ming Tseng
    Department of Surgery, Taipei Veterans General Hospital, No 201 Sec 2 Shih Pai Road, Taipei 112, Taiwan
    Breast Cancer Res 14:R68. 2012
  4. ncbi request reprint Adenocarcinomas arising from primary retroperitoneal teratoma in an adult female patient
    Pei Yi Chu
    Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho Su Memorial Hospital, Taipei, Taiwan
    Int J Urol 13:1352-4. 2006

Collaborators

  • Ling Ming Tseng
  • Kung Chi Chang
  • Chung Wai Shiau
  • Chun Yu Liu
  • Kuen Feng Chen

Detail Information

Publications4

  1. ncbi request reprint Primary superficial basal cell carcinoma of the nipple
    Pei Yi Chu
    Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho Su Memorial Hospital, Shih Lin, Taipei, Taiwan
    Ann Saudi Med 27:296-7. 2007
  2. ncbi request reprint A retroperitoneal bronchogenic cyst successfully treated by laparoscopic surgery
    Pei Yi Chu
    Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho Su Memorial Hospital, Shih Lin, Taipei, Taiwan
    Ann Saudi Med 27:199-200. 2007
  3. pmc CIP2A is a target of bortezomib in human triple negative breast cancer cells
    Ling Ming Tseng
    Department of Surgery, Taipei Veterans General Hospital, No 201 Sec 2 Shih Pai Road, Taipei 112, Taiwan
    Breast Cancer Res 14:R68. 2012
    ..Bortezomib, a proteasome inhibitor, may exert efficacy in TNBC through its multiple cellular effects. Here, we tested the efficacy of bortezomib and examined the drug mechanism in breast cancer cells...
  4. ncbi request reprint Adenocarcinomas arising from primary retroperitoneal teratoma in an adult female patient
    Pei Yi Chu
    Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho Su Memorial Hospital, Taipei, Taiwan
    Int J Urol 13:1352-4. 2006
    ..Herein is reported the first case of malignant teratoma with prominent component of signet ring cell carcinoma...